49
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Endogenous Endophthalmitis Secondary to Infected Cutaneous Basal Cell Carcinoma: A Case Report

, MD, , MDORCID Icon, , MD, , MD, , MD, , MD & , MDORCID Icon show all
Pages 355-357 | Received 05 Sep 2022, Accepted 03 Jan 2023, Published online: 25 Jan 2023
 

ABSTRACT

Introduction

Endogenous endophthalmitis (EE) is a severe intraocular infection due to hematogenous spread of bacteria from an extraocular site. Recognition of the primary source of hematogenous spread of bacteria is essential to establish an adequate therapy and avoid other major complications. Infected cutaneous tumor has never been reported as a possible source of EE.

Purpose

To describe the first case of EE due to hematogenous spread of methicillin-sensitive Staphylococcus aureus from an infected cutaneous basal cell carcinoma. Systemic antibiotic therapy and surgical excision of the cutaneous lesion were performed.

Conclusion

Severe and long-standing skin infections should be considered as a rare cause of EE.

Disclosure statement

No potential conflict of interest was reported by the authors.

Financial disclosures

Riccardo Carbonaro, Matteo Menean, Giuseppe Cottone, Mario Alessandri Bonetti, Luca Vaienti, Elisabetta Miserocchi: None

Francesco Bandello consultant for: AbbVie (North Chicago, Illinois, USA), Alimera (Alpharetta, Georgia, USA), Bayer Shering-Pharma (Berlin, Germany), Hoffmann-La-Roche (Basel, Switzerland), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee,Belgium), Boehringer-Ingelheim (Ingelheim am Rhein, Germany), Fidia Sooft, Ntc Pharma, Sifi.

Contributorship statement

All the authors contributed to the conception or design of the work, the acquisition, analysis, and interpretation of data, drafting the work, and revising it critically for important intellectual content. Each coauthor has seen and agrees with how his name is listed.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.